Aprogen Biologics Market Cap

Aprogen Biologics has a market cap or net worth of 116.17 billion as of December 5, 2025. Its market cap has decreased by -29.41% in one year.

Market Cap

116.17B

Enterprise Value

332.21B

Revenue

74.91B

Ranking

n/a

PE Ratio

n/a

Stock Price

588.00

Market Cap Chart

Since January 5, 1996, Aprogen Biologics's market cap has increased from 3.18B to 116.17B, an increase of 3,552.58%. That is a compound annual growth rate of 12.77%.

Market Cap History

Date	Market Cap	% Change
Dec 5, 2025	116.17B	-11.18%
Dec 30, 2024	130.79B	-31.41%
Dec 28, 2023	190.68B	-4.89%
Dec 29, 2022	200.48B	-44.42%
Dec 30, 2021	360.71B	-31.18%
Dec 30, 2020	524.12B	60.07%
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 28, 2017	Pro	Pro
Dec 29, 2016	Pro	Pro
Dec 30, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Samsung Biologics	77.77T
Celltrion	39.95T
ALTEOGEN	27.76T
ABL Bio	11.08T
SK Biopharmaceuticals	10.61T
Yuhan	8,911.91B
LigaChem Biosciences	7,139.05B
Peptron	6,540.52B

Market Cap Rankings